Stem cell therapy market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 9.75% in the above mentioned forecast period and is likely to reach value USD 22.47 billion by 2029.
Global Stem Cell Therapy Market Scope and Market Size
The stem cell therapy market is segmented on the basis of type, technology, product, applications and end users. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on type, the stem cell therapy market is segmented into allogeneic stem cell therapy and autologous stem cell therapy. The allogeneic stem cell therapy is further sub-segmented into musculoskeletal disorders, wounds and injuries, surgeries, acute graft-versus-host disease (AGVHD) and other. The autologous stem cell therapy is further sub-segmented into wounds and injuries, cardiovascular diseases, gastrointestinal diseases and others.
On the basis of technology, the stem cell therapy market is segmented into cell acquisition, cell production, cryopreservation and expansion and sub-culture. The cell acquisition is further sub segmented into bone marrow harvest, umbilical blood cord and apheresis. The cell production is further sub segmented into therapeutic cloning, In-vitro fertilization, cell culture and isolation.
On the basis of product, the stem cell therapy market is segmented into adult stem cells, human embryonic stem cells and induced pluripotent stem cells.
Based on application, the stem cell therapy market is segmented into musculoskeletal disorders, wounds, injuries, cardiovascular diseases, surgeries, gastrointestinal diseases and other applications.
Stem cell therapy market has also been segmented based on the end users into therapeutic companies, cell and tissues banks, tools and reagent companies and service companies.
Get the sample copy of Report here:
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-stem-cell-therapy-market
Stem Cell Therapy Market Country Level Analysis
Stem cell therapy market is analyzed and market size information is provided by the country, type, technology, product, applications and end users as referenced above.
The countries covered in the stem cell therapy market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the stem cell therapy market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Stem Cell Therapy Market Share Analysis
Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to stem cell therapy market research.
Key Players Stem Cell Therapy Market
AbbVie Inc.
Cellular Engineering Technologies,
STEMCELL Technologies Inc.,
Pharmicell Co., Ltd.,
ANTEROGEN.CO.,LTD.,
MEDIPOST, Osiris,
Lineage Cell Therapeutics, Inc.,
Takara Bio Inc.
U.S. Stem Cell, Inc.,
BrainStorm Cell Limited.,
Caladrius Biosciences, Inc.
Thermo Fisher Scientific Inc.,
Astellas Pharma Inc.,
Athersys, Inc.,
Cytori Therapeutics Inc.,
Fate Therapeutics,
Pluristem Inc.,
Vericel Corporation,
ViaCyte, Inc.,
ROSLINCT,
Regeneus Ltd.
Mesoblast Ltd.,
ReNeuron Group plc,
ISCO,
Cryo-Cell,
Geron,
Get Full Access of Report :
https://www.databridgemarketresearch.com/reports/global-stem-cell-therapy-market
MAJOR TOC OF THE REPORT
Ø Chapter One: Introduction
Ø Chapter Two: Market Segmentation
Ø Chapter Three: Market Overview
Ø Chapter Four: Executive Summary
Ø Chapter Five: Premium Insights
Ø Chapter Six: Global Stem Cell Therapy Market by Product & Procedure type
Get TOC Details:
https://www.databridgemarketresearch.com/toc/?dbmr=global-stem-cell-therapy-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
